0
Chronic Kidney Disease Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Original Research |  2 August 2016 ONLINE FIRST
Trends in Prevalence of Chronic Kidney Disease in the United StatesTrends in Prevalence of Chronic Kidney Disease in the United States
Daniel Murphy, MD; Charles E. McCulloch, PhD; Feng Lin; et al.
Ann Intern Med. Published online 2 August 2016 doi:10.7326/M16-0273
Editorials |  2 August 2016 ONLINE FIRST
Decreasing Prevalence of Chronic Kidney Disease in the United States: A Cause for OptimismDecreasing Prevalence of Chronic Kidney Disease in the United States
Linda F. Fried, MD, MPH; Paul M. Palevsky, MD
Ann Intern Med. Published online 2 August 2016 doi:10.7326/M16-1649
Reviews |  5 April 2016
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease: A Systematic Review and Meta-analysisErythropoietin-Stimulating Agents in Anemia of Chronic Kidney Disease
David Collister, MD; Paul Komenda, MD, MHA, CHE; Brett Hiebert, MSc; et al.
Ann Intern Med. 2016;164(7):472-478. doi:10.7326/M15-1839
In the Clinic |  2 June 2015
Chronic Kidney Disease
Paul Drawz, MD, MHS, MS; Mahboob Rahman, MD, MS
Ann Intern Med. 2015;162(11):ITC1. doi:10.7326/AITC201506020
In the Clinic |  3 February 2009
Chronic Kidney Disease
Paul Drawz, MD, MHS; Mahboob Rahman, MD, MS
Ann Intern Med. 2009;150(3):ITC2-1. doi:10.7326/0003-4819-150-3-200902030-01002
ACP Journal Club |  16 February 2016
Review: More- vs less-intensive BP-lowering regimens reduce major CV events
Saurav Chatterjee, MD; Partha Sardar, MD; Anasua Chakraborty, MD; et al.
Ann Intern Med. 2016;164(4):JC14. doi:10.7326/ACPJC-2016-164-4-014
ACP Journal Club |  21 April 2015
In type 2 diabetes, saxagliptin increased HF hospitalizations, regardless of history of HF or CKD
Danae A. Delivanis, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2015;162(8):JC11. doi:10.7326/ACPJC-2015-162-8-011
ACP Journal Club |  18 November 2014
Review: In AF with CKD, novel oral anticoagulants reduce stroke or systemic embolism compared with warfarin
Thomas DeLoughery, MD, FACP, FAWM
Ann Intern Med. 2014;161(10):JC4. doi:10.7326/0003-4819-161-10-201411180-02004
Summaries for Patients
Summaries for Patients |  17 December 2013 FREE
Screening, Monitoring, and Treatment of Early Stage Chronic Kidney Disease: Recommendations From the American College of Physicians
Ann Intern Med. 2013;159(12):I-28. doi:10.7326/0003-4819-159-12-201312170-00728
Summaries for Patients |  16 October 2012 FREE
Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement
Ann Intern Med. 2012;157(8):I-50. doi:10.7326/0003-4819-157-8-201210160-00534
Summaries for Patients |  2 August 2005 FREE
Effects of Dialysis Type on Survival in Patients with End-Stage Kidney Disease
Ann Intern Med. 2005;143(3):I-17. doi:10.7326/0003-4819-143-3-200508020-00001
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)